Skip to main content

News

News
04/01/2025
Vektor Medical Press Release  SAN DIEGO -- Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the publication of a groundbreaking case in Heart Rhythm Case...
Vektor Medical Press Release  SAN DIEGO -- Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the publication of a groundbreaking case in Heart Rhythm Case...
Vektor Medical Press...
04/01/2025
EP Lab Digest
News
04/01/2025
The European Society of Cardiology (ESC) has urged the European Commission to revise the Medical Device Regulation (EU 745/2017, MDR) following significant challenges in its implementation.
The European Society of Cardiology (ESC) has urged the European Commission to revise the Medical Device Regulation (EU 745/2017, MDR) following significant challenges in its implementation.
The European Society of...
04/01/2025
EP Lab Digest
News
04/01/2025
In new research presented at EHRA 2025,  a scientific congress of the European Society of Cardiology, researchers show that, compared with the general population with no history of antidepressant (AD) use, individuals with a history of AD use...
In new research presented at EHRA 2025,  a scientific congress of the European Society of Cardiology, researchers show that, compared with the general population with no history of antidepressant (AD) use, individuals with a history of AD use...
In new research presented at...
04/01/2025
EP Lab Digest
EHRA 2025 news
News
04/01/2025
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy.
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy.
The European Society of...
04/01/2025
EP Lab Digest
News
04/01/2025
While everybody’s heart has an absolute chonological age (as old as that person is), hearts also have a theoretical ‘biological’ age1 that is based on how the heart functions.
While everybody’s heart has an absolute chonological age (as old as that person is), hearts also have a theoretical ‘biological’ age1 that is based on how the heart functions.
While everybody’s heart has an...
04/01/2025
EP Lab Digest
News
04/01/2025
Christopher M. Kramer, MD, FACC, today assumed the role of president of the American College of Cardiology.
Christopher M. Kramer, MD, FACC, today assumed the role of president of the American College of Cardiology.
Christopher M. Kramer, MD, FACC,...
04/01/2025
EP Lab Digest
News
04/01/2025
At 3 months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with...
At 3 months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with...
At 3 months of follow-up,...
04/01/2025
EP Lab Digest
News
04/01/2025
The American College of Cardiology Press Release CHICAGO (Mar 30, 2025) - The overall survival rate of athletes who suffer sudden cardiac arrest has improved over the past decade, but the likelihood of surviving varies by...
The American College of Cardiology Press Release CHICAGO (Mar 30, 2025) - The overall survival rate of athletes who suffer sudden cardiac arrest has improved over the past decade, but the likelihood of surviving varies by...
The American College of...
04/01/2025
EP Lab Digest
News
04/01/2025
The American College of Cardiology Press Release  CHICAGO (Mar 29, 2025) - People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience...
The American College of Cardiology Press Release  CHICAGO (Mar 29, 2025) - People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience...
The American College of...
04/01/2025
EP Lab Digest
News
03/31/2025
iRhythm Technologies Press Release  SAN FRANCISCO, March 31, 2025 -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of...
iRhythm Technologies Press Release  SAN FRANCISCO, March 31, 2025 -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American College of...
iRhythm Technologies Press...
03/31/2025
EP Lab Digest